DisGeNET is a knowledge management platform that integrates and standardizes the data of genes and mutations related to diseases from multiple sources. It covers entire range of human disease.
Source | Last Updated |
---|---|
DisGeNET | July 29, 2024 |
Disease ID | Disease Name | Gene Symbol | Gene ID ▲ | Gene Name | UniProt ID |
---|---|---|---|---|---|
C0041207 | Truncus Arteriosus, Persistent | TMEM260 | 54916 | transmembrane protein 260 | Q9NX78 |
C0024305 | Lymphoma, Non-Hodgkin | TMEM260 | 54916 | transmembrane protein 260 | Q9NX78 |
C1306459 | Primary malignant neoplasm | TMEM260 | 54916 | transmembrane protein 260 | Q9NX78 |
C0006826 | Malignant Neoplasms | TMEM260 | 54916 | transmembrane protein 260 | Q9NX78 |
C0001973 | Alcoholic Intoxication, Chronic | TMEM260 | 54916 | transmembrane protein 260 | Q9NX78 |
C1565489 | Renal Insufficiency | TMEM260 | 54916 | transmembrane protein 260 | Q9NX78 |
C0023467 | Leukemia, Myelocytic, Acute | TMEM260 | 54916 | transmembrane protein 260 | Q9NX78 |
C1458155 | Mammary Neoplasms | ADPRS | 54936 | ADP-ribosylserine hydrolase | Q9NX46 |
C0235946 | Cerebral atrophy | ADPRS | 54936 | ADP-ribosylserine hydrolase | Q9NX46 |
C3714756 | Intellectual Disability | ADPRS | 54936 | ADP-ribosylserine hydrolase | Q9NX46 |
C0029089 | Ophthalmoplegia | ADPRS | 54936 | ADP-ribosylserine hydrolase | Q9NX46 |
C1863512 | HYPERCHOLESTEROLEMIA, AUTOSOMAL RECESSIVE | ADPRS | 54936 | ADP-ribosylserine hydrolase | Q9NX46 |
C0524851 | Neurodegenerative Disorders | ADPRS | 54936 | ADP-ribosylserine hydrolase | Q9NX46 |
C0038379 | Strabismus | ADPRS | 54936 | ADP-ribosylserine hydrolase | Q9NX46 |
C0006142 | Malignant neoplasm of breast | ADPRS | 54936 | ADP-ribosylserine hydrolase | Q9NX46 |
C0005745 | Blepharoptosis | ADPRS | 54936 | ADP-ribosylserine hydrolase | Q9NX46 |
C0036572 | Seizures | ADPRS | 54936 | ADP-ribosylserine hydrolase | Q9NX46 |
C0007785 | Cerebral Infarction | ADPRS | 54936 | ADP-ribosylserine hydrolase | Q9NX46 |
C0028738 | Nystagmus | ADPRS | 54936 | ADP-ribosylserine hydrolase | Q9NX46 |
C0600139 | Prostate carcinoma | LPCAT2 | 54947 | lysophosphatidylcholine acyltransferase 2 | Q7L5N7 |
C1136382 | Sclerocystic Ovaries | LPCAT2 | 54947 | lysophosphatidylcholine acyltransferase 2 | Q7L5N7 |
C0376358 | Malignant neoplasm of prostate | LPCAT2 | 54947 | lysophosphatidylcholine acyltransferase 2 | Q7L5N7 |
C1832661 | ANOPHTHALMIA AND PULMONARY HYPOPLASIA | LPCAT2 | 54947 | lysophosphatidylcholine acyltransferase 2 | Q7L5N7 |
C0009402 | Colorectal Carcinoma | LPCAT2 | 54947 | lysophosphatidylcholine acyltransferase 2 | Q7L5N7 |
C0032460 | Polycystic Ovary Syndrome | LPCAT2 | 54947 | lysophosphatidylcholine acyltransferase 2 | Q7L5N7 |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
GlyCosmos Portal v4.0.0
Last updated: August 19, 2024